Found: 21
Select item for more details and to access through your institution.
CD13 as a new tumor target for antibody-drug conjugates: validation with the conjugate MI130110.
- Published in:
- Journal of Hematology & Oncology, 2020, v. 13, n. 1, p. 1, doi. 10.1186/s13045-020-00865-7
- By:
- Publication type:
- Article
Therapeutic potential of an anti-CCR9 mAb evidenced in xenografts of human CCR9<sup>+</sup> tumors.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.825635
- By:
- Publication type:
- Article
CD4+ T Cell Immune Specificity Changes After Vaccination in Healthy And COVID-19 Convalescent Subjects.
- Published in:
- Frontiers in Immunology, 2022, p. 1, doi. 10.3389/fimmu.2021.755891
- By:
- Publication type:
- Article
A Differential Signature of Circulating miRNAs and Cytokines Between COVID-19 and Community-Acquired Pneumonia Uncovers Novel Physiopathological Mechanisms of COVID-19.
- Published in:
- Frontiers in Immunology, 2022, v. 12, p. 1, doi. 10.3389/fimmu.2021.815651
- By:
- Publication type:
- Article
Retrospective comparison between COBE SPECTRA and SPECTRA OPTIA apheresis systems for hematopoietic progenitor cells collection for autologous and allogeneic transplantation in a single center.
- Published in:
- Journal of Clinical Apheresis, 2020, v. 35, n. 5, p. 453, doi. 10.1002/jca.21826
- By:
- Publication type:
- Article
P-Selectin preserves immune tolerance in mice and is reduced in human cutaneous lupus.
- Published in:
- Scientific Reports, 2017, p. 41841, doi. 10.1038/srep41841
- By:
- Publication type:
- Article
Monoclonal Antibody Therapies for Hematological Malignancies: Not Just Lineage-Specific Targets.
- Published in:
- Frontiers in Immunology, 2018, p. 1, doi. 10.3389/fimmu.2017.01936
- By:
- Publication type:
- Article
NFκB and NLRP3/NLRC4 inflammasomes regulate differentiation, activation and functional properties of monocytes in response to distinct SARS-CoV-2 proteins.
- Published in:
- Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-46322-8
- By:
- Publication type:
- Article
Evaluation of Natalizumab Pharmacokinetics and Pharmacodynamics: Toward Individualized Doses.
- Published in:
- Frontiers in Neurology, 2021, v. 12, p. 1, doi. 10.3389/fneur.2021.716548
- By:
- Publication type:
- Article
Effect of ibrutinib on CCR7 expression and functionality in chronic lymphocytic leukemia and its implication for the activity of CAP-100, a novel therapeutic anti-CCR7 antibody.
- Published in:
- Cancer Immunology, Immunotherapy, 2022, v. 71, n. 3, p. 627, doi. 10.1007/s00262-021-03014-2
- By:
- Publication type:
- Article
Preclinical activity of anti-CCR7 immunotherapy in patients with high-risk chronic lymphocytic leukemia.
- Published in:
- Cancer Immunology, Immunotherapy, 2015, v. 64, n. 6, p. 665, doi. 10.1007/s00262-015-1670-z
- By:
- Publication type:
- Article
Immediate Effects of Dasatinib on the Migration and Redistribution of Naïve and Memory Lymphocytes Associated With Lymphocytosis in Chronic Myeloid Leukemia Patients.
- Published in:
- Frontiers in Pharmacology, 2019, v. 10, p. 1, doi. 10.3389/fphar.2019.01340
- By:
- Publication type:
- Article
Ibrutinib Does Not Impact CCR7-Mediated Homeostatic Migration in T-Cells from Chronic Lymphocytic Leukemia Patients.
- Published in:
- Cancers, 2022, v. 14, n. 11, p. 2729, doi. 10.3390/cancers14112729
- By:
- Publication type:
- Article
The NOTCH1/CD44 axis drives pathogenesis in a T cell acute lymphoblastic leukemia model.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Of Lymph Nodes and CLL Cells: Deciphering the Role of CCR7 in the Pathogenesis of CLL and Understanding Its Potential as Therapeutic Target.
- Published in:
- Frontiers in Immunology, 2021, v. 11, p. N.PAG, doi. 10.3389/fimmu.2021.662866
- By:
- Publication type:
- Article
Novel Germline TET2 Mutations in Two Unrelated Patients with Autoimmune Lymphoproliferative Syndrome-Like Phenotype and Hematologic Malignancy.
- Published in:
- Journal of Clinical Immunology, 2023, v. 43, n. 1, p. 165, doi. 10.1007/s10875-022-01361-y
- By:
- Publication type:
- Article
Glutathione overproduction mediates lymphoma initiating cells survival and has a sex-dependent effect on lymphomagenesis.
- Published in:
- Cell Death & Disease, 2024, v. 15, n. 7, p. 1, doi. 10.1038/s41419-024-06923-z
- By:
- Publication type:
- Article
Evaluation of the novel therapeutic anti‐CCR7 antibody CAP‐100 as an add‐on therapy in chronic lymphocytic leukemia patients receiving venetoclax.
- Published in:
- Hematological Oncology, 2023, v. 41, n. 5, p. 869, doi. 10.1002/hon.3213
- By:
- Publication type:
- Article
Anti-CCR7 therapy exerts a potent anti-tumor activity in a xenograft model of human mantle cell lymphoma.
- Published in:
- Journal of Hematology & Oncology, 2013, v. 6, n. 1, p. 3, doi. 10.1186/1756-8722-6-89
- By:
- Publication type:
- Article
PSGL-1, ADAM8, and selectins as potential biomarkers in the diagnostic process of systemic lupus erythematosus and systemic sclerosis: an observational study.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1403104
- By:
- Publication type:
- Article
Somatic mTOR mutation in clonally expanded T lymphocytes associated with chronic graft versus host disease.
- Published in:
- Nature Communications, 2020, v. 11, n. 1, p. 1, doi. 10.1038/s41467-020-16115-w
- By:
- Publication type:
- Article